SB392 Alabama 2015 Session

Summary

Primary Sponsor

Tim MelsonSenator

Republican

Session

Regular Session 2015

Title

Epinephrine, auto-injectors, authorize administration of by non medical persons, program created

Summary

SB392 would create a program to let non-medical people stock and use single-dose epinephrine auto-injectors at places where severe allergic reactions may occur, with training, public access stations, and liability protections.

What This Bill Does

It allows certain non-school entities to stock epinephrine auto-injectors and train staff to administer them in emergencies. It creates Emergency Public Access Stations that store auto-injectors and enable real-time consultation with a medical professional. It authorizes good-faith administration or provision of epinephrine by trained individuals and provides immunity from certain lawsuits, while requiring reporting of incidents and giving the Department of Public Health authority to issue rules.

Who It Affects

• Authorized entities (such as recreation camps, colleges, day cares, youth sports leagues, amusement parks, restaurants, workplaces, and sports arenas) and their employees or agents; they may stock auto-injectors, train staff, store injectors, and receive liability immunity.
• Individuals at risk of anaphylaxis (and their parents or guardians) and lay rescuers who may use epinephrine through authorized entities or EPAS; they gain access to timely treatment and protections when acting in good faith.

Key Provisions

• Creates a program for providing single-dose epinephrine auto-injectors to laypersons through authorized entities at locations where allergens may cause anaphylaxis.
• Authorizes authorized entities to stock epinephrine auto-injectors via prescriptions in the entity's name and requires staff training and designated oversight for storage and use.
• Establishes Emergency Public Access Stations (EPAS) that store auto-injectors and allow real-time consultation with a health professional before use.
• Allows any individual to use EPAS or administer epinephrine in good faith for suspected anaphylaxis, with immunity from liability except in cases of gross negligence; requires incident reporting to the Department of Public Health.
• Requires initial and biennial anaphylaxis training for staff and allows the Department of Public Health to adopt related rules and approve training entities.

AI-generated summary using openai/gpt-5-nano on Feb 24, 2026. May contain errors — refer to the official bill text for accuracy.

Subjects

Epinephrine